Prior work in SAH populations found that more than half of patients with SAH were prescribed opioids at discharge, many of whom had continued opioid use at outpatient follow-up. However, there are limited data describing opioid prescribing patterns and long-term usage among patients with ICH. Given differences in underlying pathophysiology, demographics, and patient characteristics, it is possible that risk factors for opioid use in patients with ICH may be unique, compared with SAH and other neurological disorders. Therefore, we aimed to describe the rates of short-term and longer-term opioid use in patients with acute ICH and identify potential risk factors that might warrant increased awareness in the acute setting and beyond.